4//SEC Filing
Burhop Kenneth 4
Accession 0001209191-20-010232
CIK 0000917520other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 4:59 PM ET
Size
11.6 KB
Accession
0001209191-20-010232
Insider Transaction Report
Form 4
Burhop Kenneth
CORPVP,CHIEFSCIENTIFIC OFFICER
Transactions
- Award
Common Stock
2020-02-13+1,303→ 13,768 total - Award
Common Stock
2020-02-13+654→ 14,422 total - Award
Common Stock
2020-02-13+678→ 15,100 total
Footnotes (3)
- [F1]On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019, at least 9% and up to a maximum of 33% cumulative increase in annual revenue over the 2016 fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 34% of the shares will vest on March 13, 2020 at 150% of target, the third anniversary of the grant date.
- [F2]On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the second anniversary of the grant date.
- [F3]On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2019 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the first anniversary of the grant date.
Issuer
INTEGRA LIFESCIENCES HOLDINGS CORP
CIK 0000917520
Entity typeother
Related Parties
1- filerCIK 0001601582
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 4:59 PM ET
- Size
- 11.6 KB